Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States.
about
ERbeta in breast cancer--onlooker, passive player, or active protector?Conditional median survival of patients with advanced carcinoma: surveillance, epidemiology, and end results data.Racial/ethnic differences in breast cancer survival by inflammatory status and hormonal receptor status: an analysis of the Surveillance, Epidemiology, and End Results data.Race/ethnicity and breast cancer estrogen receptor status: impact of class, missing data, and modeling assumptions.Comparison of multiplex ligation dependent probe amplification to immunohistochemistry for assessing HER-2/neu amplification in invasive breast cancer.Association of MTHFR gene polymorphisms with breast cancer survival.A mammography database and view system for African-American patients.Differences in the tumor microenvironment between African-American and European-American breast cancer patientsS-phase fraction and breast cancer--a decade of experience.Breast cancer treatment and ethnicity in British Columbia, CanadaExpression of aldehyde dehydrogenase 1 (ALDH1) is associated with basal-like markers and features of aggressive tumours in African breast cancer.Race and breast cancer survival by intrinsic subtype based on PAM50 gene expression.The religiosity/spirituality of Latina breast cancer survivors and influence on health-related quality of lifeHypothesized role of pregnancy hormones on HER2+ breast tumor development.Assessing the Racial and Ethnic Disparities in Breast Cancer Mortality in the United StatesBreast cancer and the immune systemComparative analysis of breast cancer risk factors among Hispanic and non-Hispanic white women.Family history and breast cancer hormone receptor status in a Spanish cohort.Racial/ethnic disparities in time to follow-up after an abnormal mammogramInfluence of Hispanic ethnicity on outcome after resection of carcinoma of the head of the pancreas.Breast cancer survival among economically disadvantaged women: the influences of delayed diagnosis and treatment on mortality.Impact of breast carcinoma on African-American women: the Detroit experience.Differential expression of breast cancer-associated genes between stage- and age-matched tumor specimens from African- and Caucasian-American Women diagnosed with breast cancer.Enhanced down-regulation of ALCAM/CD166 in African-American Breast Cancer.Breast feeding, parity and breast cancer subtypes in a Spanish cohortBreast and cervical screening by race/ethnicity: comparative analyses before and during the Great RecessionDietary intake of folate, B-vitamins and methionine and breast cancer risk among Hispanic and non-Hispanic white women.Temporal trends in the black/white breast cancer case ratio for estrogen receptor status: disparities are historically contingent, not innateAssociations of hormone-related factors with breast cancer risk according to hormone receptor status among white and African American womenRace and family history assessment for breast cancer.Toward optimal screening strategies for older women. Costs, benefits, and harms of breast cancer screening by age, biology, and health status.Race and the prognostic influence of p53 in women with breast cancer.Inflammatory and non-inflammatory breast cancer survival by socioeconomic position in the Surveillance, Epidemiology, and End Results database, 1990-2008.Race, socioeconomic status, and breast carcinoma in the U.S: what have we learned from clinical studies.A novel intervention using interactive technology and personal narratives to reduce cancer disparities: African American breast cancer survivor stories.Clinical and pathological characteristics of Hispanic BRCA-associated breast cancers in the American-Mexican border city of El Paso, TX.Differentially expressed transcripts and dysregulated signaling pathways and networks in African American breast cancer.Interactions among genes, tumor biology and the environment in cancer health disparities: examining the evidence on a national and global scaleA comparison of clinicopathological features and molecular markers in british and nigerian women with breast cancerThe satisfaction of Latina breast cancer survivors with their healthcare and health-related quality of life.
P2860
Q30438399-C81CE358-C8CD-4EDA-A943-FE77058BE8A0Q30662240-DA69C431-7C43-4760-85FA-A04175600355Q30823443-4AC0269C-A148-44B1-829C-CB080E31C4CDQ31171709-A4DDC917-AA5D-44F2-9363-6A75C06BD266Q33253893-1DF1204A-911A-4AA2-A2CB-1CF2AD1CD75BQ33261851-E3F01117-9EE6-4ABE-9502-8A85055E5E7AQ33280428-DFE11C65-4933-44FF-B166-5832DE240F02Q33410258-FCFB553D-930E-4E70-85D8-A9634408D491Q33539158-070C7305-81A1-4E6F-8D9D-ECDF0B1C29E2Q33560497-5CABE877-7BB8-4AF8-9D23-9AC280D82AAEQ33630849-EEF45EAB-8199-4AAD-A402-E5F13E8584DAQ33669007-8BE5CBBE-870F-4396-A44F-1049C11A77FEQ33680988-20B9F218-BFAB-41A4-9EC5-F2A0EB736453Q33745434-5D8C5D08-D40E-45E2-A330-03A2F8FCABBFQ33748595-74BBAF3D-48C6-45E3-BD8F-8D7FD6BEB4A4Q33753043-DE33DD3D-5AF9-4EEF-889D-62EEF697F161Q34067452-80615AE9-E908-4217-8930-1FDE34294404Q34125091-65FAC645-D8A0-44E6-9018-93B44EFFDBA7Q34141799-6A2F81A0-11A5-4F23-85BB-EA95B6014971Q34194504-0F206DF0-CF05-4EDC-94B3-6DB04AD7375BQ34222510-EB4137FD-7D5F-4DEA-906B-4BA83D3D34EAQ34240437-E2EF2E07-271A-43B5-A75D-F1A5CA22B03BQ34278253-63D62EB3-A26D-4B57-9168-EC321EA9499BQ34309546-C39B62B1-BCC5-4987-85AD-7D65E8AD1325Q34336498-3A77405A-C907-49AF-935A-512299111D3DQ34378374-4895231D-60EA-475C-A785-FCBBD70B7FD0Q34585881-A3CADAB5-9271-4B64-9DC5-3FD0D2573383Q34590337-EC363CB1-A4E5-4306-B5FE-A3026FE771B7Q34619821-B21EDE59-9246-40B2-BE55-A51CD379D32CQ34722568-BAC726AD-2C8B-4169-A6AB-92740C3C1CECQ34723307-92781E52-2B4E-4E75-B98F-296DCBCC4A4AQ34796332-BCBE3A94-0783-4B1A-B04C-47242289E640Q34918360-67CC3F59-17FF-4154-90F5-1EA6C904492EQ34982473-0883086F-CE39-4B67-A03A-0C4E6038AA3FQ34986195-C94ED538-1278-43ED-9F0A-6AE0E06DB3DFQ34991306-4360972F-C272-47A4-AECF-1891CB93ADFDQ35064200-5078FF0C-6002-49E9-8BDE-2A3FABC0C9CEQ35144499-173DF249-5B9C-472E-9A2C-E98DB157E7C4Q35181036-33B67C51-88C7-4365-B07F-FD7B7C217AEEQ35185355-3805B0CC-A7DB-425E-ADCB-20B0DD4AED4C
P2860
Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh-hant
name
Tumor biologic factors and bre ...... ck women in the United States.
@en
Tumor biologic factors and bre ...... ck women in the United States.
@nl
type
label
Tumor biologic factors and bre ...... ck women in the United States.
@en
Tumor biologic factors and bre ...... ck women in the United States.
@nl
prefLabel
Tumor biologic factors and bre ...... ck women in the United States.
@en
Tumor biologic factors and bre ...... ck women in the United States.
@nl
P2093
P356
P1476
Tumor biologic factors and bre ...... ck women in the United States.
@en
P2093
Chamness GC
Elledge RM
Osborne CK
P304
P356
10.1093/JNCI/86.9.705
P407
P577
1994-05-01T00:00:00Z